Indications for pelvic lymphadenectomy in clinically localized prostate cancer;Indications de la lymphadénectomie ilio-obturatrice dans le cancer de la prostate cliniquement localisé

Progres en Urologie

Volumn 14, Issue 3, 2004, Pages 287-294

  Peneau, Michel ^a   Villers, Arnauld ^b   Molinie, Vincent ^c   Theis, Didier ^b   Soulie, Michel ^d  

^a CENTRE HOSPITALIER RÉGIONAL D ORLÉANS   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c FOCH HOSPITAL   (France)

^d CHU RANGUEIL   (France)

Author keywords

Lymphadenectomy; Neoplasm; Nodes; Pathology; Prostate; Staging

Indexed keywords

CANCER GRADING; CANCER INVASION; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; FROZEN SECTION; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; LAPAROSCOPY; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; PELVIS LYMPHADENECTOMY; PRACTICE GUIDELINE; PREOPERATIVE EVALUATION; PROSTATE CARCINOMA; PROSTATECTOMY; RADIATION FIELD; REVIEW; RISK ASSESSMENT; SURGEON; SYSTEMATIC REVIEW; TISSUE SECTION; TREATMENT INDICATION;

HUMANS; LAPAROSCOPY; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; NEOPLASM STAGING; PELVIS; PRACTICE GUIDELINES; PROGNOSIS; PROSTATIC NEOPLASMS;

EID: 4143097014     PISSN: 11667087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (68)

1. ALAGIRI M., COLTON M.D., SEIDMON E.J., GREENBERG R.E., HANNO P.M. : The staging. Br pelviclymphadenectomy: implications as an adjunctive procedure for clinically localized prostate cancer. J. Urol., 1997 ; 80 : 243-246.
2. AUS G., ABBOU C.C., PACIK D., SCHMID H.P., VAN POPPEL H., WOLFF J.M., ZATTONI F : EAU Working Group on Oncological Urology. EAU guidelines on prostate cancer. Eur. Urol., 2001 ; 40 : 97-101.
3. BADER P., BURKHARD F.C., MARKWALDER R., STUDER U.E. : Is a limited lymph node dissection an adequate staging procedure for prostate cancer ? J. Urol., 2002 ; 168 : 514-518.
4. BADER P., BURKHARD F.C., MARKWALDER R., STUDER U.E. : Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure ? J. Urol., 2003 ; 169 : 849-854.
5. BAZINET M., HAMDY S.M., BEGIN L.R., STEPHENSON R.A., FAIR WR. : Pronostic significance and antigenic heterogeneity Gleason grade, and ploïdy of lymph node metastases in patients with prostate cancer. Prostate, 1992 ; 20 : 311-326.
6. BEISSNER R.S., STRICKER J.B., SPEIGHTS V.O., COFFIELD K.S., SPIEKERMAN A.M., RIGGS M. : Frozen section diagnosis of metastatic prostate adenocarcinoma in pelvic iymphadenectomy compared with nomogram prediction of metastasis. Urology, 2002 ; 59 : 721-725.
7. BLUESTEIN D.L., BOSTWICK D.G., BERGSTRALH E.J., OESTERLING J.E. : Eliminating the need for bilateral pelvic lymphadenectomy in select patients with prostate cancer. J. Urol., 1994 ; 151 : 1315-1320.
8. BRANT L.A., BRANT W.O., BROWN M.H., SEID D.L., ALLEN R.E. JR. : A new minimally invasive open pelvic lymphadenectomy surgical technique for the staging of prostate cancer. Urology, 1996 ; 47 : 416-421.
9. BRAWN P., KUHL D., JOHNSON C., PANDYA P., MCCORD R. : Stage D1 prostate carcinoma the histologic appearance of nodal metastases and its relationship to survival. Cancer, 1190 ; 65 : 538-543.
10. BRENDLER C.B., CLEEVE L.K., ANDERSON E.F. AND PAULSON D.F. : Staging pelvic lymphadenectomy for carcinoma of the prostate : risk versus benefit. J. Urol., 1980 ; 124 : 849-850.
11. BURKHARD F., BADER P., STUDER U.E. : Survival of lymph node positive patients after radical prostatectomy. Eur. Urol., suppl., 39 : Abstr 136, 2001.
12. BURKHARD F., BADER P., SCHNEIDER E., MARKWALDER R., STUDER U. : Reliability of preoperative values to determine the need for lymphadenectomy in patients with prostate cancer and meticulous lymph node dissection. Eur. Urol., 2002 ; 42 : 84.
13. CAMPBELL S.C., KLEIN E.A., LEVIN H.S., PIEMONTE M.R. : Open pelvic lymph node dissection for prostate cancer: a reassessment. Urology, 1995 ; 46: 352-355.
14. CHENG L., SLEZAK J., BERGSTRALH E.J., CHEVILLE J.C., SWEAT S., ZINCKE H., BOSTWICK D.G. : Dedifferenciation in the metastatic progression of prostate carcinoma. Cancer, 1999 ; 86 : 657-663.
15. CHENG L., ZINCKE H., BLUTE M.L., BERGSTRALH E.J., SCHERER B., BOSTWICK D.G. : Risk of prostate carcinoma death in patients with lymph node metastasis. Cancer, 2001 ; 91 : 66-73.
16. CRAWFORD E.D., BATUELLO J.T., SNOW P., GAMITO E.J., MCLEOD D.G., PARTIN A.W., STONE N., MONTIE J., STOCK R., LYNCH J., BRANDT J. The use of artificial intelligence technology to predict lymph node spread in men with clinically localized prostate carcinoma. Cancer, 2000 ; 88 : 2105-2109.
17. DANELLA J.F., DEKERNION J.B., SMITH R.B., STECKEL J. : The contemporary incidence of lymph node metastases in prostate cancer: implications for laparoscopic lymph node dissection. J. Urol., 1993 ; 149 : 1488-1491.
18. DAVIS G.L. : Sensitivy of frozen section examination of pelvic lymph nodes for metastatic prostate carcinoma. Cancer, 1995 ; 76 : 661-668.
19. DELREGADO J.A., ACKERMANN L.V. : Diagnosis, Treatment and Prognosis of Cancer, 4th ed. St. Louis: The C. V. Mosby Co., p 654, 1977.
20. EPSTEIN J.I., OESTERLING J.E., EGGLESTON J.C., WALSH P.C. Frozen section detection of lymph node metastases in prostatic carcinoma: Accuracy in grossly uninvolved pelvic lymphadenectomy specimens. J. Urol., 1986 ; 136 : 1234-1237.
21. FUJIOKA T., KOIKE H., AOKI H., OHHORI T., CHIBA R., OKAMOTO S. Significance of staging pelvic lymphadenectomy for prostatic cancer. Urol. Int., 1987 ; 42 : 380-384.
22. GERVASI L.A., MATA J., EASLEY J.D., WILBANKS J.H., SEALE-HAWKINS C., CARLTON C.E., SCARDINO P.T. : Pronostic significance of lymph nodal metastases in prostate cancer. J. Urol., 1989 ; 142 : 332-336.
23. GIL-VERNET J.M. : Prostate cancer: anatomical and surgical considerations. Br. J. Urol., 1996 ; 78 : 161-168.
24. GOLIMBU M., PROVET J., AL ASKARI S., MORALES P. : Radical prostatectomy for stage D1 prostate cancer. Prognostic variables and results of treatment. Urology, 1987 ; 30 : 427-435.
25. GOMELLA L.G., WHITE J.L., MCCUE P.A., BYRNE D.S., MULHOLLAND S.G. : Screening for occult nodal metastasis in localized carcinoma of the prostate. J. Urol., 1993 ; 149 : 776-778.
26. GUAZZONI G., MONTORSI F., BERGAMASCHI F., BELLINZONI P., CENTEMERA A., CONSONNI P., RIGATTI P. : Open surgical revision of laparoscopic pelvic lymphadenectomy for staging of prostate cancer : The impact of laparoscopic learning curve. J. Urol., 1994 ; 151 : 930-933.
27. HAESE A., EPSTEIN J.I., HULAND H., PARTIN A.W. : Validation of a biopsy-based pathologic algorithm for predicting lymph node metastases in patients with clinically localized prostate carcinoma. Cancer, 2002 ; 95 : 1016-1021.
28. HEIDENREICH A., VARGA Z., VON KNOBLOCH R. : Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis. J. Urol., 2002 ; 167 : 1681-1686.
29. HERRELL S.D., TRACHTENBERG J., THEODORESCU D. : Staging pelvic lymphadenectomy for localized carcinoma of the prostate: a comparison of 3 surgical techniques. J. Urol., 1997 ; 157 : 1337-1339.
30. HULL G.W., RABBANI F., ABBAS F., WHEELER T.M., KATTAN M.W., SCARDINO P.T. : Cancer control with radical prostatectomy alone in 1000 consecutive patients. J. Urol., 2002 ; 167 : 528-534.
31. KAKEHI Y., KAMOTO T., OKUNO H., TERAI A., TERACHI T., OGAWA O. : Per-operative frozen section examination of pelvic nodes is unnecessary for the majority of clinically localized prostate cancers in the prostate-specific antigen era. Int. J. Urol., 2000 ; 7 : 281-286.
32. KAVOUSSI L.R., SOSA E., CHANDHOKE G., CHODAK G., CLAYMAN R.V., HADLEY H.R., LOUGHLIN K.R., RUCKLE H.C., RUKSTALIS D., SCHUESSLER W. : Complications of laparoscopic pelvic lymph node dissection. J. Urol., 1993 ; 149 : 322-325.
33. KERBL K., CLAYMAN R.V., PETROS J.A., CHANDHOKE P.S., GILL LS. : Staging pelvic lymphadenectomy for prostate cancer: a comparison of laparoscopic and open technique. Urology, 1993 ; 150 : 396-398.
34. KUEFER R., LOEFFLER M., RUBIN M.A. : Do patients with locally advanced prostate cancer and high Gleason score as negative predictive marker benefit from radical prostatectomy? J. Urol., 167 (suppl. 4) : Abstr 696, 2002.
35. LEVRAN Z., GONZALEZ J.A., DIOKNO A.C., JAFRI S.Z.H., STEINERT B.W. : Are pelvic computed tomography, bone scan and pelvic lymphadenectomy necessary in the staging of prostatic cancer ? Br. J. Urol., 1995 ; 75 : 778-781.
36. LEZIN M.S., CHERRIE R., CATTOLICA E.V. : Comparison of laparoscopic and mini-laparotomy pelvic lymphadenectomy for prostate cancer staging in a community practice. Urology, 1997 ; 49 : 60-63.
37. LINK R.E., MORTON R.A. : Indications for pelvic lymphadenectomy in prostate cancer. Urol. Clin. North. Am., 2001 ; 28 : 491-4981.
38. MESSING E., MANOLA J., SAROSDY M., WILDING G., CRAWFORD E.D., TRUMP D. Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer. New England J. Med., 1999 ; 341 : 1781-1788.
39. NOGUCHI M., STAMEY T.A., MCNEAL J.E., YEMOTO C.M. : Preoperative serum prostate specific antigen does not reflect biochemical failure rates after radical prostatectomy in men with large volume cancer. J. Urol., 2000; 164: 1596-1600.
40. PARTIN A.W., KATTAN M.W., SUBONG E.N.P., WALSH P.C., WOJNO K.J., OESTERLING J.E., SCARDINO P.T., PEARSON J.D. : Combination of prostate specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. Jama, 1997 ; 277 : 1445-1451.
41. PARTIN A.W., YOO J., CARTER H.B., PEARSON J.D., CHAN D.W., EPSTEIN J.I., WALSH P.C. : The use of prostate specific antigen clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J. Urol., 1993 ; 150 : 110-115.
42. PERROTTI M., GENTLE D.L., BARADA J.H., WILBUR H.J., KAUFMAN R.P. JR. : Mini laparotomy pelvic lymph node dissection minimizes morbidity, hospitalisation and cost of pelvic lymph node dissection. J. Urol., 1996 ; 155 : 986-988.
43. PETROS J.A., CATALONA W.J. : Lower incidence of unsuspected lymph node metastases in 521 consecutive patients with clinically localized prostate cancer. J. Urol., 1992 ; 147 : 1574-1575.
44. PLAWKER M.W., FLEISHER J.M., VAPNEK E.M., MACCHIA R.J. : Current trends in prostate cancer diagnosis and staging among United States urologists. J. Urol., 1997 ; 158 : 1853-1858.
45. PROUT G.R., HEANEY J.A., GRIFFIN P.P., DALY J.J., SHIPLEY W.U. : Nodal involvement as a prognostic indicator in patients with prostatic carcinoma. J. Urol., 1980 ; 124 : 226-231.
46. PUPPO P., PERACHINO M. : Clinical stage, prostate specific antigen and Gleason grade to predict extracapsular disease or nodal metastasis in men with newly diagnosed, previously un treated prostate cancer. A multicenter study. Eur. Urol., 1997 ; 32 : 273-279.
47. COMITE DE CANCEROLOGIE DE L'ASSOCIATION FRANÇAISE D'UROLOGIE : Recommandations 2002, Prog. Urol., 2002 ; 12 : 31-67.
48. REES M.A., CAMPBELL S.C., KLEIN E.A., CLEVELAND O.H., PARTIN A.W., WALSH P.C. Validation of a model for predicting metastatic disease in the pelvic lymph nodes of patients with clinically localized prostate cancer. J. Urol., 1996; 155 : 487a.
49. REES M.A., MC HUGH T.A., DORR R.P., SOLOMON M.H., LEE F., LITTRUP P., ARBOR A., GONZALEZ J.A., LEVRAN Z. Assessment of the utility of bone scan, CT scan and lymph node dissection staging of patients with newly diagnosed prostate cancer. J. Urol., 1995 ; 153 : 352a.
50. REES M.A., RESNICK M.I., OESTERLING J.E. : Use of prostate specific antigen Gleason score, and digital rectal examination in staging patients with newly diagnosed prostate cancer. Urol. Clin. North Am., 1997 ; 24 : 379-388.
51. RUKSTALIS D.B., GERBER G.S., VOGELZANG HARAF D.J., STRAUS F.H., CHODAK G. W. : Laparoscopic pelvic lymph node dissection : a review of 103 consecutive cases. J. Urol., 1994 ; 151 : 670-674.
52. SCHUBERT J., HEIDL G. : Lymphogenic metastases in prostatic cancer: operative and histopathologic investigations. Arch. Geschwulstforsch, 1982; 52: 213-221.
53. SCHUESSLER W.W., PHARAND D., VANCAILLIE T.G. : Laparoscopic standart pelvic lymph node dissection for carcinoma of the prostate : is it accurate? J. Urol., 1993 ; 150 : 898.
54. SGRIGNOLI A.R., STEINER M., WALSH P.C., EPSTEIN J.I. : Histologic parameters at the time of frozen section detection of prostate cancer nodal metastases to identify patients unlikely to benefit form radical prostatectomy. Mod. Pathol., 1993 ; 6 : 69a.
55. SGRIGNOLI A.R., WALSH P.C., STEINBERG G.D., STEINER M.S., EPSTEIN J.I. : Pronostic factors in men with stage D1 prostate cancer: identification of patients less likely to have prolonged survival after radical prostatectomy. J. Urol., 1994 ; 152 : 1077-1081.
56. SMITH J.A., MIDDLETON R.G. : Implications of volume of nodal metastasis in patients with adenocarcinoma of the prostate. J. Urol., 1985 ; 133 : 617-6195.
57. STAMEY T.A., MCNEAL J.E., YEMOTO C.M., SIGAL B.M., JOHNSTONE I.M. : Biological determinants of cancer progression in men with prostate cancer. JAMA, 1999 ; 281 : 1395-1400.
58. STEINBERG G.D., EPSTEIN J.I., PIANTADOSI S., WALSH P.C. : Management of stage D1 adenocarcinoma of the prostate. The Johns Hopkins experience 1974 to 1987. J. Urol., 1990 ; 144 : 1425-1432.
59. STONE N.N., STOCK R.G., UNGER P. : Laparoscopic pelvic lymph node dissection for prostate cancer: comparison of the extended and modified techniques. J. Urol., 1997 ; 158 : 1891-1894.
60. TROXEL S.A., WIENFIELD H.N. : Comparative financial analysis of laparoscopic pelvis lymph node dissection performed in 1990-1992 versus 1993-1994. J. Endo. Urol., 1996 ; 10 : 353-359.
61. VILLERS A., POMMIER P., BATAILLARD A., FERVERS B., BACHAUD J.M., BERGER N., BERTRAND N. Fédération Nationale des Centres de Lutte Contre le Cancer, (ed), Cancer de la prostate non métastatique (Non M, Vol. 14, Paris: John Libbey EUROTEXT; Standarts Options & Recommendations.
62. WALSH P.C. : Radical prostatectomy: a procedure in evolution. Semin. Oncol., 1994 ; 21 : 662-671.
63. WAWROSCHEK F., VOGT H., WECKERMANN D., WAGNER T., HAMM M., HARZMANN R. : Radioisotope guided pelvic lymph node dissection for prostate cancer. J. Urol., 2001 ; 166 : 1715-1719.
64. WEINGARTNER K., RAMASWAMY A., BITTINGER A., GERHARZ E.W., VOGE D., RIEDMILLER H. : Anatomical basis for pelvic lymphadenectomy in prostate cancer: results of an autopsy study and implications for the clinic. J. Urol., 1996 ; 156 : 1969-1971.
65. WILKINSON E.J., HAUSE E. : Probability in lymph node sectioning. Cancer, 1974 ; 33 : 1269-1274.
66. YOUNG M.P., KIRBY R.S., O'DONOGHUE E.P., PARKINSON M.C. : Accuracy and cost of intra operative lymph node frozen sections at radical prostatectomy. J. Clin. Pathol., 1999 ; 52 : 925-927.
67. ZINCKE H., BERGSTRALH E.J., LARSON-KELLER J.J., FARROW G.M., MYERS R.P., LIEBER M.M., BARRETT D.M, RIFE C.C., GONCHOROFF N.J. : Stage D1 prostate cancer treated by radical prostatectomy and adjuvant hormonal treatment. Evidence for favorable survival in patients with DNA diploïd tumors. Cancer, 1992 ; 70 : 311-323.
68. ZINCKE H., UTZ D.C., TAYLOR W.F. : Bilateral pelvic lymphadenectomy and radical prostatectomy for clinical stage C prostate cancer : role of adjuvant treatment for residual cancer and in disease progression. J. Urol., 1986; 135 : 1199-1205.